Hepatic failure and hepatorenal syndrome secondary to erlotinib: a possible etiology of complications in a patient with pancreatic cancer.
Publication/Presentation Date
9-6-2010
Volume
11
Issue
5
First Page
484
Last Page
485
ISSN
1590-8577
Published In/Presented At
Gunturu, K. S., Abu-Khalaf, M., & Saif, M. W. (2010). Hepatic failure and hepatorenal syndrome secondary to erlotinib: a possible etiology of complications in a patient with pancreatic cancer. JOP : Journal of the pancreas, 11(5), 484–485.
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
20818124
Department(s)
Administration and Leadership
Document Type
Article
COinS